DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
9.48
-0.51 (-5.11%)
Mar 6, 2026, 1:37 PM EST - Market open
DarioHealth Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for DarioHealth stock have an average target of 50, with a low estimate of 40 and a high estimate of 60. The average target predicts an increase of 427.43% from the current stock price of 9.48.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 19, 2025.
Analyst Ratings
The average analyst rating for DarioHealth stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Litchfield Hills | Litchfield Hills | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +532.91% | May 19, 2025 |
| Stifel | Stifel | Strong Buy Maintains $70 → $40 | Strong Buy | Maintains | $70 → $40 | +321.94% | Mar 11, 2025 |
| Stifel | Stifel | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +743.88% | Apr 1, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $109 → $82 | Strong Buy | Maintains | $109 → $82 | +764.98% | Aug 11, 2023 |
| Stifel | Stifel | Strong Buy Maintains $180 → $120 | Strong Buy | Maintains | $180 → $120 | +1,165.82% | Jul 25, 2023 |
Financial Forecast
Revenue This Year
22.62M
from 27.04M
Decreased by -16.35%
Revenue Next Year
26.27M
from 22.62M
Increased by 16.15%
EPS This Year
-6.79
from -12.27
EPS Next Year
-4.39
from -6.79
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.5M | 28.7M | |||
| Avg | 22.6M | 26.3M | |||
| Low | 21.6M | 21.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -13.1% | 27.0% | |||
| Avg | -16.3% | 16.1% | |||
| Low | -20.0% | -4.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.07 | -3.33 | |||
| Avg | -6.79 | -4.39 | |||
| Low | -10.19 | -5.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.